Vimarsana
Biggest News Aggregation in the World

Page 12 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

Air Methods Successfully Completes Financial Restructuring - Vimarsana News

Air Methods Successfully Completes Financial Restructuring

Emerges from Chapter 11 with Optimal Capital Structure and Enhanced Financial Flexibility...

MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million - Vimarsana News

MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million

- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec for the treatment of X-linked retinitis pigmentosa for a total of up to $415 million - MeiraGTx to receive...

Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - Vimarsana News

Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

AUSTIN, TX and DURHAM, NC, Dec. 21, 2023 -- Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic...

MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 ... - Vimarsana News

MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 ...

- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) for a total of up to $415

Ascendis Pharma A/S : Form 6-K -December 13, 2023 at 04:07 pm EST - Vimarsana News

Ascendis Pharma A/S : Form 6-K -December 13, 2023 at 04:07 pm EST

Ascendis Pharma A/S Name, Registered Office and Objects of the Company: Article 1 ...